These high frequencies in the FAM46C, TP53, BRAF, and NRAS rates might be in line with either successive relapses and/or secondary plasma cell leukemia (PCL), from which HMCLs are mostly derived [25–29]. Here, BRAF is linked to plasma cell leukemia.